Redeye remains cautiously optimistic to OXE following last evenings two-sided release with, on the one hand, a new EUR 2.8m LOI in the US, and on the other hand, reduced growth targets for 2020. As we already had a conservative stance on OXE's growth prospects for 2020, expecting 30% vs. targeted 50+%, the news does not affect our current base case valuation or our forecasts.